Clinical trial
Study Comparing 13-valent Pneumococcal Conjugate Vaccine With 7-valent…
NCT00373958 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00373958 |
|---|---|
| Title | Study Comparing 13-valent Pneumococcal Conjugate Vaccine With 7-valent Pneumococcal Conjugate Vaccine |
| Official title | A Phase 3, Randomized, Active-Controlled, Double-blind Trial Evaluating the Safety, Tolerability and Immunologic Noninferiority of a 13-valent Pneumococcal Conjugate Vaccine Compared to a 7-valent Pneumococcal Conjugate Vaccine in Healthy Infants Given With Routine Pediatric Vaccinations in the… |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Vaccines, Pneumococcal |
| Intervention type | Biological |
| Interventions | 13 valent pneumococcal conjugate vaccine, 7vPnc pneumococcal conjugate vaccine |
| Enrollment | 666 |
| Start date | Sep 1, 2006 |
| Primary completion | Jun 1, 2008 |
| Completion | Jun 1, 2008 |
| First posted | Sep 8, 2006 |
| Last update posted | Feb 21, 2013 |
| Countries | United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: